Narcolepsy following COVID‐19: A case report and review of potential mechanisms

KEY CLINICAL MESSAGE: The immune activation in COVID‐19 may trigger narcolepsy in vulnerable patients. We suggest clinicians carefully evaluate patients with post‐COVID fatigue and hypersomnia for primary sleep disorders, specifically narcolepsy. ABSTRACT: The patient is a 33‐year‐old Iranian woman...

Descripción completa

Detalles Bibliográficos
Autores principales: Roya, Yazdani, Farzaneh, Barzkar, Mostafa, Almasi‐Dooghaee, Mahsa, Shojaie, Babak, Zamani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213711/
https://www.ncbi.nlm.nih.gov/pubmed/37251741
http://dx.doi.org/10.1002/ccr3.7370
Descripción
Sumario:KEY CLINICAL MESSAGE: The immune activation in COVID‐19 may trigger narcolepsy in vulnerable patients. We suggest clinicians carefully evaluate patients with post‐COVID fatigue and hypersomnia for primary sleep disorders, specifically narcolepsy. ABSTRACT: The patient is a 33‐year‐old Iranian woman without a significant past medical history with the full range of narcolepsy symptoms that started within 2 weeks after her recovery from COVID‐19. Sleep studies revealed increased sleep latency and three sleep‐onset rapid eye movement events, compatible with a narcolepsy‐cataplexy diagnosis.

Ejemplares similares